16 news items
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
15 Jun 24
of its officers and/or directors have engaged in securities
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
13 Jun 24
whether Regeneron and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market
REGN
13 Jun 24
likely to be engaged with a clinician would translate to $20 billion in U.S. sales just in COPD in 2026—far above our prior $1.4 billion estimate
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
5 Jun 24
concerns whether Regeneron and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals
REGN
4 Jun 24
systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate
wdbbecgnzog3l7tize2ik8nh
REGN
3 Jun 24
concerns whether Regeneron and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
mbkpnyh596vgfu0f1ag
REGN
30 May 24
of its officers and/or directors have engaged in securities
2ddrt7exactjx3lkat3shiv1iykg52w2a4cqv1mnwasysc16 uewlw
REGN
28 May 24
whether Regeneron and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
u9g6avl3imx uxuzme230gdcq6ax7itag2ubtc
REGN
22 May 24
of its officers and/or directors have engaged in securities
vp1w 9q44frifo74p6xu7yafgibi1pg2bdn02x22sbgxjoczd9rn
REGN
20 May 24
whether Regeneron and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
cuymqg ju1zkq0rs6e6357jtz7av4fpbs5vbj3hputxp7st7tduy
DV
JBL
REGN
19 May 24
whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each
0w12t43adkiroyq8 1ec2uvj4edxp
REGN
16 May 24
and/or engaged in other unlawful business practices
7z2 fifcwmt9w6mi3
REGN
18 Apr 24
). The investigation concerns whether Regeneron and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful
pi20zrvj4cel9ch
REGN
17 Apr 24
) on behalf of Regeneron stockholders. Our investigation concerns whether Regeneron has violated the federal securities laws and/or engaged in other
uxgtdfn2j1qp69nhe8miaz4iyizyriosushx
ARGX
ATNM
MRNA
28 Mar 24
to engage with a company that is not only contributing to the advancement of cancer treatment but also setting new standards in medical isotope
64eu8hy2fy2128 ootgny7x0
REGN
26 Mar 24
, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter
- Prev
- 1
- Next